Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04425824 |
|---|---|
| Brief Title: | Toripalimab Combine With Rituximab for Treatment of Relapsed Refractory CD20 Positive Diffuse Large B-cell Lymphoma |
| First Submitted : | June 4, 2020 |
| First Submitted that Met QC Criteria : | June 7, 2020 |
| First Posted : | June 11, 2020 |
| Last Update Submitted that Met QC Criteria : | June 12, 2020 |
| Last Update Posted : | June 16, 2020 |